EBS_EU_Health_02_RGB_24

European Health Summit 2026

8 & 9 December

Résidence Palace , Brussels

The European Health Summit is a neutral and independent platform that brings together key health stakeholders to improve decision-making on Europe’s health system challenges.

Through open, balanced dialogue across public, private, and societal perspectives, EHS provides a trusted space to examine complex issues at the intersection of health policy, economic reality, and societal values. By confronting trade-offs openly, EHS strengthens mutual understanding among decision-makers and stakeholders, shaping Europe’s health systems.

Each year, EHS focuses on a set of priority themes reflecting the most pressing challenges facing European health systems. In 2026, these include: Health as Europe’s Strategic Economic Engine; Biotech Act & Innovation Leadership; AI, Data & Digital Infrastructure for Health and Geopolitics, Trade & Health Security.

Discover the 2026 speakers

Marjorie Michel
Minister of Health, Government of Canada
Ana Paula Martins
Minister of Health, Government of Portugal
Sébastien Martin
Minister Delegate of Industry, Government of France
Daniel Naumovas
Vice-Minister of Health, Government of Lithuania
Victor Negrescu
Vice-President of the European Parliament
Laurent Muschel
Deputy Director-General, DG HERA, European Commission
Marjan Šarec
Member of the European Parliament
Aurelijus Veryga
Member of the European Parliament
Steve Mahoney
President and Chief Executive Officer, Viridian Therapeutics
Pedro Espirito Santo
Policy Assistant to European Commissioner Jozef Síkela
Ciaran Nicholl
Director, Health and Food, Joint Research Centre, European Commission
Kasia Jurczak
Head of Unit, Combating Disease, DG RTD, European Commission
Lisa Stasi
Vice President and General Manager Global Pharma Strategy and EU Region, Ecolab
Georg Schroeckenfuchs
Cluster Head of SERCE, Novartis
Emma Charles
Senior Vice President European Markets, Bristol-Myers Squibb
Emanuele Degortes
Vice President, Global Head of Access Policy, Patient Advocacy & Engagement
Colin Russell
Professor of Applied Evolutionary Biology, University of Amsterdam Faculty of Medicine and Chair European Scientific Working Group on Influenza and other Respiratory Viruses (ESWI)
Daniel Rankin
Head of Strategy & Corporate Development, Sobi
Carmen Laplaza Santos
Head of Unit, Health Innovations and Ecosystems, DG RTD, European Commission
Hervé Lamarque
Head of Business Unit Inflammation & Autoimmunity (IAI) International, Incyte
Jeffrey Francer
Vice President, Head of International Regulatory Affairs and Global Regulatory Policy, Eli Lilly and Company
Jennifer Lee
VP Market Access & Government Affairs, Viridian Therapeutics
Arnaud Thysen
Director General, European Business Summits
Sarah-Taïssir Bencharif
EU Health Journalist

Contact us

Felicia Balan
Head of Health & Demographics Department
+32 (0)2 645 3 484
Alejandro Gutierrez De Teran Bueno
Health Project & Policy Officer
+32 (0)2 349 35 95

Check the 2026 Agenda

Our mission is twofold: we aim to bring politics and business together in order to provide them with an opportunity to debate and pursue their common goals, giving a voice to all sides of the debate. The other priority of EBS is to provide European institutions with a platform where they can place their top priorities in the spotlight and advance the development of new pieces of legislation through discussion with a variety of actors and stakeholders.

Arnaud Thysen
Director General

They trust us

Among other: